Canadian psychedelics firm MindBio Therapeutics Corp. (CSE: MBIO) on Friday released durability results from its Phase 2A trial for its patented take-home microdose version of lysergic acid diethylamide (LSD), designed to treat depression with “sub-hallucinogenic” doses. The trial found the drug “is a safe and effective drug for treating depression …

The Ohio Division of Cannabis Control has received 235 applications thus far from businesses hoping to either land recreational marijuana retail permits or add that feature to their existing medical cannabis shops. Some of the applications have already been approved, ABC 6 reported, which included medical marijuana growers, processors, and …

An independent analysis by FTI Consulting on the potential of the Pennsylvania recreational marijuana market found that the state could hit up to $2.8 billion in sales in the first year of operations and create nearly 45,000 jobs. The study, paid for by nonprofit coalition Responsible PA, is part of …

Verano Holdings Corp. (OTC: VRNOF)  Chief Operating Officer Trip McDermott spoke with Green Market Report’s Executive Editor Debra Borchardt recently at the Benzinga New Jersey conference. McDermott spoke about the company’s rising revenue, along with the upcoming Ohio market. In addition to that he talked about the potential for Florida …